Vice President Harris prescribed Covid-19 treatment reserved for “high-risk” patients

Dr. Marty Makary, professor of medicine at John Hopkins Hospital, revealed that Vice President Kamala Harris is on Paxlovid, which according to him, is “a drug reserved for high-risk patients.”

Dr. Makary stated that he was “surprised to learn” that the Vice President was on Paxlovid. News about the Vice President is scant right now and with this recent revelation, could Vice President Harris be dangerously ill with Covid-19?

Yale Medicine published an article about Paxlovid and explained that “The FDA authorized Paxlovid for people ages 12 and older who weigh at least 88 pounds. But in order to qualify for a prescription, you must also have had a positive COVID-19 test result and be at high risk for developing severe COVID-19.”

Vice President Harris is neither elderly nor is she unvaccinated, which makes her Paxlovid prescription even stranger.

Paxlovid is generally prescribed to either elderly, unvaccinated, or immunocompromised individuals. Going by those conventions, it is possible that the Vice President is somehow immuno-compromised.

Of course, it is unlikely that the White House is going to release any information about the Vice President, and Press Secretary Jen Psaki is highly unlikely to answer any questions.

Right now, all the information we have from the White House is a tweet from the Vice President herself.

Vice President Harris tested positive for Covid-19 on Tuesday and tweeted an announcement saying, “Today I tested positive for COVID-19. I have no symptoms, and I will continue to isolate and follow CDC guidelines. I’m grateful to be both vaccinated and boosted.”

This will certainly be a situation to keep an eye on as the health of the Vice President is extremely important. Hopefully, the White House will recognize the importance of transparency and give the American people some answers on the state of the Vice President.